NCT01433107

Efficacy and Safety of Terbinafine Film Forming Solution in Patients With Tinea Pedis

A Randomized, Double-blind, Placebo-controlled, Multicenter, Parallel Group Study of the Efficacy and Safety of Terbinafine Film Forming Solution, 1% (as Hydrochloride), in Patients With Tinea Pedis

• Status: Completed
• Phase: Phase 3
• Study type: Interventional
• Enrollment: 290 (actual)
• Sponsor: Novartis · Industry
• Sex: All
• Age: 18 Years
• Healthy volunteers: Not accepted

Summary

This study will compare the efficacy and safety of a single dose of terbinafine film forming solution 1% with a single dose of placebo film forming solution in the treatment of tinea pedis.

Conditions

• Tinea Pedis

Interventions

Type	Name	Description
DRUG	Terbinafine	1% single application
DRUG	Terbinafine Placebo	single application

Timeline

• Start date: 2011-08-01
• Primary completion: 2012-02-01
• Completion: 2012-02-01
• First posted: 2011-09-13
• Last updated: 2013-12-27
• Results posted: 2013-12-27

Locations

6 sites across 1 country: China